

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Sanghi Steve | director, officer: President, CEO and Chair of Bd | A-Award | 24,841 | — |
Daily · Wilder smoothing
| Oct 1, 26 |
| Sanghi Steve |
| director, officer: President, CEO and Chair of Bd |
| A-Award |
| 16,560 |
| — |
| Oct 1, 26 | Krawczyk Joseph R Ii | officer: SR. CORP VP, WW CLIENT ENGMT | A-Award | 1,672 | — |
| Oct 1, 26 | Krawczyk Joseph R Ii | officer: SR. CORP VP, WW CLIENT ENGMT | A-Award | 1,672 | — |
| Oct 1, 26 | Duvenhage Stephanus | officer: Sr. Corp VP, Analog Bus Unit | A-Award | 1,609 | — |
| Oct 1, 26 | Duvenhage Stephanus | officer: Sr. Corp VP, Analog Bus Unit | A-Award | 1,608 | — |
| Oct 1, 26 | Bunker Mathew B | officer: SR CORPORATE VP, OPERATIONS | A-Award | 1,911 | — |
| Oct 1, 26 | Bunker Mathew B | officer: SR CORPORATE VP, OPERATIONS | A-Award | 1,911 | — |
Classic floor pivots from 2026-10-19
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 46.82 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 32.40 | Oscillator | Neutral |
| Williams %R (14) | -65.76 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.50 (Hist -0.49) | Oscillator | Strong Sell |
| Average Directional Index (14) | 14.17 (+DI 23.0 / -DI 23.5) | Trend | Neutral |
| EMA 20 | 75.46 | MA | Sell |
| SMA 20 | 76.63 | MA | Sell |
| EMA 50 | 76.62 | MA | Sell |
| SMA 50 | 75.55 | MA | Sell |
| SMA 200 | 79.49 | MA | Strong Sell |
Stock news · updated daily
Integrated Advisors Network LLC reduced its position in Microchip Technology Incorporated (NASDAQ: MCHP) by 74.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,918 shares of the semiconductor company's stock after selling 31,405 shares during the quarter. Integrated
The company's L-Series timing devices are designed to scale between COTS and traditional space-grade solutions, offering shorter lead times at competitive price points The company's L-Series timing devices are designed to scale between COTS and traditional space-grade solutions, offering shorter lead times at competitive price points
High-quality real-world data has been a major bottleneck for teaching robot hands: A video can show movement without measuring touch or force.
Microchip Tech (MCHP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
The average of price targets set by Wall Street analysts indicates a potential upside of 49% in Microchip Tech (MCHP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Microchip Tech (MCHP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
First Citizens Bank and Trust Co. reduced its holdings in shares of Microchip Technology Incorporated (NASDAQ: MCHP) by 30.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,919 shares of the semiconductor company's stock after selling 17,449 shares
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | 0.70 | 0.76 | Beat 8.6% | $1.48B |
| May 7, 2026 | 0.51 | 0.57 | Beat 12.9% | $1.31B |
| Feb 5, 2026 | 0.43 | 0.44 | Beat 2.7% | $1.19B |
| Nov 6, 2025 | 0.33 | 0.35 | Beat 5.9% | $1.14B |
| Aug 7, 2025 | 0.24 | 0.27 | Beat 13.0% | $1.08B |
| May 8, 2025 | 0.10 | 0.11 | Beat 5.1% | $970.5M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 5, 2026 | 2026-10-05 17:14:05 | View |
| 4 | Oct 5, 2026 | 2026-10-05 17:13:12 | View |
| 4 | Oct 5, 2026 | 2026-10-05 17:12:08 | View |
| 4 | Oct 5, 2026 | 2026-10-05 17:10:28 | View |
| 4 | Oct 5, 2026 | 2026-10-05 17:09:20 | View |
| 4 | Sep 2, 2026 | 2026-09-02 16:31:17 | View |
| 4 | Sep 2, 2026 | 2026-09-02 16:30:35 | View |
| 4 | Sep 2, 2026 | 2026-09-02 16:28:41 | View |
| 3 | Aug 28, 2026 | 2026-08-28 17:26:45 | View |
| 3 | Aug 28, 2026 | 2026-08-28 17:25:26 | View |
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | MCHP | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 103.1x | -1872.9x · sector 44.2x | Elevated |
| Forward P/E (FY27E) | 20.4x | EPS est. 3.65 | Discount |
| Price / Book | 6.3x | 6.1x | In line |
| Price / Sales | 7.9x | 6.3x | Elevated |
| EV / EBITDA | 27.0x | 20.8x | Elevated |
| Return on equity | 6.9% | — | Weak |
| Gross margin | 60.2% | 62.4% | In line |
| Debt / Equity | 0.84 | 0.98 | Moderate |
| Piotroski / Altman Z | 7/9 | Z 4.18 | Safe zone |
Discounted cash flow model
Current price $74.43
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 21, 26 | BMO Capital | maintain | Outperform | Outperform |
| Aug 17, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Aug 7, 26 | Truist Securities | maintain | Hold | Hold |
| Aug 7, 26 | Rosenblatt | maintain | Buy | Buy |
| Aug 7, 26 | Citigroup | maintain | Buy | Buy |
| Aug 7, 26 | UBS | maintain | Buy | Buy |
| Aug 3, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Jul 20, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Jul 13, 26 | TD Cowen | maintain | Hold | Hold |
FY2026 · 10-K disclosure